stu nicholls dot com | menu - Professional dropdown #3

Who's Online

6 user(s) are online (6 user(s) are browsing News)

Members: 0
Guests: 6

more...

Research : Research Projects
on 2008/6/28 10:40:00 (159 reads)

Hepatitis

Viral

1. Hepatitis A in Golestan, Bandar Abbas Tehran in 1384. Corresponding Researcher
2. The Impact of lamivudine therapy on progression of liver fibrosis in the patients with HBeAg (-) CHB referring to Shariati Hospital Hepatitis Clinic. Corresponding Researcher
3. Determining liver histology in HBs Ag + ive patients with normal serum ALT level seen in Hepatitis Clinic of Shariati Hospital. (from August 2003 to July 2005) Corresponding Researcher
4. Study of HBV genotype and mutation on Iranian inactive carrier and chronic hepatitis B patients Corresponding Researcher
5. Noninvasive Markers of Liver Fibrosis in Chronic Hepatitis B. Corresponding Researcher
6. Reversibility of cirrhosis in chronic hepatitis B. Related Article
7. Determining the correlation between serum hyaluronic Acid and liver fibrosis in patients with chronic hepatitis B and cirrhosis. Related Article
8. Development of a molecular system for Detection of hepatitis C viral load by Real-time RT-PCR in HCV infected patients and its comparison will QPCR-ELISA. Related Article
9. Prevalence and risk factors of Hepatitis C virus infection in hemodialysis patients and dialysis center workers. Corresponding Researcher
10. Genotyping Hepatitis c virus isolates from Iran by simplified PCR method. Corresponding Researcher
11. Prevalence of HCV infection in the Iranian hemophiliac patients referring to the Comprehensive Hemophilia Treatment Center. Corresponding Researcher
12. HCVAb in Intravenous Drug Users in Tehran, Iran . Related Article
13. Efficacy of metformin in decreasing viral load in patients with chronic hepatitis C that refer to Liver and Gastroenterology research center of Tehran Shariati hospital. Related Article
14. Relationship between Insulin resistance and response to3 month treatment with Ribavirin plus Interferon in patients with chronic hepatitis C. Corresponding Researcher
15. Response rate of treatment with Interferon A-2b plus Ribavirin in patients with chronic hepatitis C. Corresponding Researcher
16. Determination of relationship between PePHD region of Envelop glycoprotein E2gene mutations and interferon resistance in hepatitis C virus infection in Iranian patients. Related Corresponding Researcher
17. Determination of relationship between hepatitis C nonstructural protein 5A gene mutations and interferon resistance in hepatitis C virus infection. Corresponding Researcher
18. Seruprevalance of hepatitis C virus and associated risk factors: a population based study- in northeast of Golestan – Iran. Corresponding Researcher
19. Assessment of celiac disease in patients with autoimmune and B and C hepatitis. Corresponding Researcher
20. Hepatitis E seroprevalence in Golestan, Tehran, Bandar Abbas in 1384. Corresponding Researcher

Autoimmune

1. Identification of prognostic factors for response to therapy in autoimmune hepatitis patient. Corresponding Researcher
2. Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis. Related Article
3. Prospective, single center randomized controlled trial comparing efficacy and tolerability of cyclosporine A with prednisolone for induction of remission in Autoimmune hepatitis patients over 3 years. Corresponding Researcher

Metabolic

1. Prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with Hyperlipidemia. Corresponding Researcher
2. Frequency of fatty liver disease in patients with NIDDM. Corresponding Researcher
3. Validation of the Modifications on the Brunt staging and grading system for the patient with NAFLD. Related Article
4. Comparison of the effect of weight reduction on sonographic findings of patients with non alcoholic Fatty liver and controls. Corresponding Researcher
5. Prevalence of nonalcoholic fatty liver disease among first degree relatives of patients with non-alcoholic steatohepatitis attending a specialty clinic in Tehran. Corresponding Researcher
6. Pilot Study: Study of the frequency of Non-alcoholic steatosis and steatohepatitis and their diagnostic & clinical features in patients undergoing in the Surgery Ward of Shariati Hospital (in 2004). Corresponding Researcher
7. Role of small bowel bacterial overgrowth in NAFLD and NASH as compared to controls. Corresponding Researcher
8. Frequency assessment of halothane hepatitis type II and its risk factors. Corresponding Researcher
9. Phase I trial of autologous stem cell transplantation in patients with decompensated cirrhosis. Corresponding Researcher
10. Investigation of the effect of Naltrexone aclministration on Mesentric vascular bed responsiveness to phenylephrine in cirrhotic rats. Corresponding Researcher

Pancreatobiliary

1. Percutaneous Needle Aspiration, Injection, and Reaspiration with or without Benzimidazole Coverage for Uncomplicated Hepatic Hydatid Cysts. Related Article
2. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. Related Article
3. Assessing the role of Indomethacin in prevention of post-ERCP pancreatitis. Corresponding Researcher
4. Evaluation of biliary ducts diameter in opium addicts and normal population. Corresponding Researcher
5. Incidence of Cystic fibrosis in Iranian Children. Corresponding Researcher
6. Reversibility of dilated common bile duct after sphincterotomy and stone extraction in patients with choledocholithiasis. Corresponding Researcher
7. Diagnostic Value of Brush Cytology During ERCP for Pancreatobiliary Strictures. Corresponding Researcher
8. The role of EUS in Prevention of Un-necessary ERCP. Corresponding Researcher
9. Silent liver diseases in autopsies from forensic medicine of Tehran. Related Article
10. Needle-Knife Fistulotomy versus Standard Method for Cannulation of Common Bile Duct: A Randomized Controlled Trial. Corresponding Researcher

Cancer

1. Survival Analysis of Upper GI Cancer cases and study on its efficaious factors in Ardabil. 2004 –2006. Corresponding Researcher
2. Realationship between glutathione S-transferase–pi mRNA expression and cyclooxygenase-2 activity in tissue biopsies obtained from esophagitis and esophageal adenocarcinoma patients. Corresponding Researcher
3. A case-control study for risk factors of adenocarcinoma of esophagus, Gastroesophageal Junction and proximal stomach in high incidence area in north of Iran. Corresponding Researcher 1 , 2
4. Association between dietary habits, carcinogenic PAHs and fumonisin B intake via staple food and esophageal cancer in I.R.Iran. Corresponding Researcher
5. Cohort Study of Esophageal Carcinoma in the Golestan Province,Iran. Corresponding Researcher
6. Case-control study of esophageal squamouse cell carcinoma risk factors in Golestan province, main phase. Corresponding Researcher
7. Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer. Related Article
8.

Clinical characteristics and risk factors of gastric carcinoma in Shariati Hospital. Corresponding Researcher

9. Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison. Related Article
10. Ecologic Study of Serum Selenium and Upper Gastrointestinal Cancers in Iran. Related Article
11. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Related Article
12. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. Related Article
13. Salted, smoked and pickled foods as probable risk factors for cancer of stomach in Ardabil Iran. Corresponding Researcher
14. Evaluation of effectiveness of H.pylori eradication on regression of gastric precancerous lesions in 1st degree relatives of patients with gastric cancer. A long term double blind randomized controlled clinical trial. Corresponding Researcher
15. Determination Of The Diagnostic Value Of Endoscopic Brush Cytology in the esophageal and proximal gastric cancer. Corresponding Researcher
16. Assessment of risk factors and outcome of patients with primary liver cancer (Hepatocellular carcinoma). Corresponding Researcher
17. Effectiveness of a screening program for hepatocellular carcinoma and its cost effectiveness. Corresponding Researcher
18. Determining the Prevalence of precancerous (adenomatous) lesion in colon of first-degree relatives of patients with colorectal cancer ( patients 40 years old and less). Related Article
19. Determining the of mutation in mismatch repair genes in young (under 40 at the time of diagnosis) colorectal cancer patients (first phase). Corresponding Researcher
20. Determining mutation in p53 and K-RAS genes and Chromosomal instability in colorectal cancer patients who was older than 40 years at the time of diagnosis.(First phase). Related Article
21. Establishment of data and blood sample bank of patients with colorectal cancer and their first-degree relatives (First phase: patients 40 years of age or younger). Corresponding Researcher
22. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. Related Articles 1 , 2
23. Establishment a population based cancer registry in north of Iran. Related Articles 1 , 2 , 3 , 4 , 5 , 6
24. Evaluation of exposure to polycyclic aromatic hydrocarbons (PAH) in North-East of Iran (Gonbad). Related Article

Helicobacter Pylori

1. Assessment of yeast as a vector for transmission of Helicobacter pylori. Corresponding Researcher
2. Antimicrobial effectiveness of ketoconazole against metronidazole-resistant Helicobacter pylori isolates from Iranian dyspeptic patients. Related Article
3. Antimicrobial effectiveness of Furazolidone-resistance strains of Helicobacter pylori. Related Article
4. Treatment of Helicobacter pylori infection in ; low efficacy of recommended western regimens. Related Article
5. Antimicrobial effectiveness of furazolidone against metronidazole-resistant strains of Helicobacter pylori. Related Article
6. Helicobacter pylori reinfection rate 3 years after successful eradication. Related Article
7. Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine or 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial. Related Article
8. Neutralization of Helicobacter Pylori Cytotoxicity on Vero Cells by Omeprazole. Related Article
9. Second-Line Helicobacter pylori Eradication. Related Article
10. Effect of three regimens containing 2 weeks Metronidazole (M) or Furazolidone (F) or 1 week M+1 week F all in combination with Omeprazole + Bismuth derivative + Amoxicillin on H. pylori eradication in patients with duodenal ulcer. Corresponding Researcher
11. Study of Anti Helicobacter pylori activity of 20 Iranian plants and determination of the biologically active components. Corresponding Researcher

Celiac

1. Relative frequency of celiac disease in patiens with Iron deficiency anemia without known etiology that refering to hematologic clinic of Shariati Hospital. Corresponding Researcher
2. Prevalence of celiac disease in patients with osteoporosis. Corresponding Researcher
3. Comparison of the prevalence of HLA DQ2 alleles in patients with celiac disease and general population. Corresponding Researcher
4. Comparison of the prevalence of HLA DQ8 alleles in patients with celiac disease and general population. Corresponding Researcher
5. Celiac disease presenting with symptoms of irritable bowel syndrome. Related Article
6. Celiac disease in Iranian type I diabetic patients. Related Article
7. Assessment of frequency of celiac disease in Kerman. Corresponding Researcher
8. Assessment of frequency of celiac disease in Sari. Corresponding Researcher
9. Assessment of frequency of celiac disease among of patients with epilepsy. Corresponding Researcher
10. Evaluation of tissue transglutaminas (tTG) for screening of silent celiac in the children of Tehran. Corresponding Researcher
11. Determination of celiac disease occurrence in patients with recurrent aphthousstomatitis. Corresponding Researcher

Achalasia

1. Gender effect on clinical features of achalasia: a prospective study. Related Article
2. Value of timed barium esophagogram and symptom score in the assessment of patient's outcome after pneumatic dilatation in idiopathic achalasia. Related Article
3. Pneumatic balloon dilatation in achalasia: a prospective comparison of safety and efficacy with different balloon diameters. Related Article
4. Efficacy of botulinum toxin injection before pheumatic dilatation in patients with idiopathic achalasia: A controll Trial. Related Articles 1 , 2 , 3
5. Evaluation of the Prevalance of Esophagitis Before & One Year after Pneumatic Dilation in Achalasia Patients Who Reffer to Endoscopy Ward of Shariati Haspital since Khordad-85. Corresponding Researcher
6. Comparison of the efficacy of two kinds of tratment in idiopathic achalasia: Botolinum Toxin Injection and Sclerotherapy.Corresponding Researcher

GERD

1. Epidemiology of Gastro-esophageal reflux disease: A Survey in patients underwent upper gastro-esophageal endoscopy from 1993 up to 2003. Corresponding Researcher
2. Validation study of the questionnaire Quality of Life in Reflux and Dyspepsia(QOLRAD). Corresponding Researcher
3. To develop a symptom score questionnaire for gastroesophageal reflux disease among iranian outpatients and to test its reproducibility. Corresponding Researcher
4. Role of dietary habit, psychosocial status and physical activity in Gasteroesophagial reflux in Gonbad & Calaleh city in 1384. Corresponding Researche
5. Assessment of Response to Medical Treatment in GERD patients with & without Erosive Esophagitis referring to a GI Clinic. Corresponding Researcher
6. Survey of Gastroesophageal reflux disease's risk factors in Gonbad Kawus (1383). Corresponding Researcher
7. Prevalence and clinical spectrum of Gastroesophageal Reflux : A population-based study in Tehran. Corresponding Researcher
8. Assessing the intra & inter observer variation in making the diagnosis of erosive esophagitis in GERD patients referring to a GI Clinic. Related Article
9. Assessing the relation of H.Pylori existance with esophagitis & it`s severity in patients with gastroesophageal reflux disease. Corresponding Researcher
10. Assessing the impact of IBS on the response rate of GERD patients to treatment with PPIs (omeprazole). Corresponding Researcher
11. Assessing the dominancy pattern of H.pylori gastric involvement in patients with gastroesophageal reflux disease. Corresponding Researcher
12. Determining the normal value for intra epithelial lymphocytes count (I.E.Ls) in the distal of duodenum in a healthy Iranian sample of population referring consecutively to the Shariati hospitable for endoscopy. Corresponding Researcher

IBD

1. The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Related Article
2. Establishing a cohort of IBD patients referred to several clinics in Tehran from 2004 to 2007. Corresponding Researcher
3. Study of 908fs981,R702W and G908R mutations in CARD15 gene in Crohn's disease among Iranian patients. Corresponding Researcher
4. A case control study on risk factors of osteoporosis in patients with Crohn’s Disease. Corresponding Researcher
5. A case control study on risk factors of IBD in patients with IBD. Corresponding Researcher
6. Comparing the prevalence of IBS-like symptoms, in ulcerative colitis patients in remission phase with normal population. Corresponding Researcher
7. Evaluation and comparison of CTT between functional constipation and constipation predominant IBS patients in a case control study. Corresponding Researcher

Others

1. Healthy ranges of serum alanine aminotransferase levels in health Iranian population (year 1384). Related Article
2. Design, implementation and maintenance of database based on data gathered through implementation of project “An open study of Lamivudine treatment in adult HBe negative (presumed precore mutant) chronic hepatitis B in Iran. Corresponding Researcher
3. Bibliographic analysis of Iranian biomedical research output cited in Medline & EMBASE in the last decade. Related Article
4. Determining the validity and reliability of Rome II epidemiologic questionnaire in diagnosing functional gastrointestinal disorders in a 12-18-year old population. Corresponding Researcher
5. Development of a sensetive and precise INAA method, for determination of Se as a resposible element in esophageal and gastric cancer by using toenail. Corresponding Researcher
6. Lower esophagus in dyspeptic Iranian patients: a prospective study. Related Article
7. Survey of Gastrointestinal symptoms in Tehran, a Telephone Survey. Corresponding Researcher
8. Irritable Bowel Syndrome and Psychiatric Disorders Among University Freshmen. Related Article
9. Effect of several fixatives (formalin, 60 , 70 and 80% ethilic alcohol and “finfix” liquid fixative) on PCR amplification and Immunohistochemistry. Corresponding Researcher